ALZHEON
Biotechnology company with a recent SEC Form D offering.
Biotechnology company headquartered in FRAMINGHAM, MASSACHUSETTS. Filed SEC Form D on 20260910 for a $78.8M Regulation D offering.
Biotech
📍 FRAMINGHAM, MASSACHUSETTS
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is ALZHEON going public?
No. ALZHEON is private and has not filed to go public. There is no S-1 on file.
What is ALZHEON's valuation in 2026?
No confirmed valuation is on record for ALZHEON. The roster shows funding and investors where they are public; it does not estimate a mark.
Has ALZHEON filed an S-1?
No public S-1 is on file for ALZHEON.
Can you buy ALZHEON stock?
No. ALZHEON is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for ALZHEON on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
HQ
FRAMINGHAM, MASSACHUSETTS
Growth
Filed SEC Form D on 20260910 for $78.8M Regulation D offering
Last Round
Form D filing — $78.8M (20260910)
Fundraising Status
Form D filing · $78.8M
privateTotal raised $78.8M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $78.8M | 20260910 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
Registered trials
5
0 active · 0 recruiting
Lead phase
Phase 3
most advanced registered study
Focus areas
Early Alzheimer's Disease
Alzheimer Disease
Latest trial start
2024-04-02
Talent Signal
Hiring data for ALZHEON has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.